Statistics
Total Visits
Views | |
---|---|
Supplementary data for article: Šukalović, V.; Bogdan, A. E.; Tovilovic, G.; Ignjatovic, D.; Andrić, D.; Kostić-Rajačić, S.; Šoškić, V. N-{[2-(4-Phenyl-Piperazin-1-Yl)-Ethyl]-Phenyl}-Arylamides with Dopamine D-2 and 5-Hydroxytryptamine 5HT(1A) Activity: Synthesis, Testing, and Molecular Modeling. Archiv der Pharmazie 2013, 346 (10), 708–717. https://doi.org/10.1002/ardp.201300189 | 168 |
Total Visits Per Month
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
---|---|---|---|---|---|---|---|
Supplementary data for article: Šukalović, V.; Bogdan, A. E.; Tovilovic, G.; Ignjatovic, D.; Andrić, D.; Kostić-Rajačić, S.; Šoškić, V. N-{[2-(4-Phenyl-Piperazin-1-Yl)-Ethyl]-Phenyl}-Arylamides with Dopamine D-2 and 5-Hydroxytryptamine 5HT(1A) Activity: Synthesis, Testing, and Molecular Modeling. Archiv der Pharmazie 2013, 346 (10), 708–717. https://doi.org/10.1002/ardp.201300189 | 10 | 1 | 2 | 0 | 5 | 0 | 0 |
File Visits
Views | |
---|---|
N_2_4_Phenyl_sup_2013.pdf | 62 |
Top country views
Views | |
---|---|
Poland | 54 |
United States | 28 |
Sweden | 20 |
Serbia | 7 |
Bosnia & Herzegovina | 3 |
Japan | 2 |
China | 1 |
Croatia | 1 |
Italy | 1 |
Latvia | 1 |
Top cities views
Views | |
---|---|
Warsaw | 54 |
Belgrade | 6 |
Banja Luka | 3 |
Des Moines | 3 |
Tokyo | 2 |
Arezzo | 1 |
Ashburn | 1 |
Riga | 1 |
San Mateo | 1 |
Zagreb | 1 |